ACCELERATE DIAGNOSTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9301 USD | -1.61% |
|
+8.28% | -76.27% |
Chart calendar Accelerate Diagnostics, Inc.
3596925941fa8.jMPmPVmbmOkykaHE_FUhUBWvGtlKPzu0PR_Echq2yz0.uruHeTvO76ZjpJKsvwpmKn3afbEhbXCZRUaHM1mAnm_gsYRwDP7PrUX99A~8877adc0d0b62fe391be7e7c656f5b69
Upcoming events on Accelerate Diagnostics, Inc.
Past events on Accelerate Diagnostics, Inc.
| 28/03/2024 20:30 | Q4 2023 Earnings Call |
| 28/03/2024 20:05 | Q4 2023 Earnings Release |
| 09/11/2023 21:30 | Q3 2023 Earnings Call |
| 09/11/2023 21:05 | Q3 2023 Earnings Release |
| 10/08/2023 21:30 | Q2 2023 Earnings Call |
| 10/08/2023 21:05 | Q2 2023 Earnings Release |
| 19/05/2023 17:30 | Annual General Meeting |
| 11/05/2023 21:30 | Q1 2023 Earnings Call |
| 11/05/2023 21:05 | Q1 2023 Earnings Release |
| 29/03/2023 21:30 | Q4 2022 Earnings Call |
| 29/03/2023 21:05 | Q4 2022 Earnings Release |
| 14/11/2022 21:30 | Q3 2022 Earnings Call |
| 14/11/2022 21:05 | Q3 2022 Earnings Release |
| 15/08/2022 21:30 | Interim 2022 Earnings Call |
| 15/08/2022 13:15 | Interim 2022 Earnings Release |
| 07/06/2022 16:00 | William Blair Growth Stock Conference |
| 16/05/2022 21:30 | Q1 2022 Earnings Call |
| 16/05/2022 21:05 | Q1 2022 Earnings Release |
| 12/05/2022 17:30 | Annual General Meeting |
| 22/04/2022 | European Clinical Microbiology and Infectious Diseases Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,30 9,33 -0.35% | 11,2 11,2 -0.31% | 11,8 11,7 0.7% | 12,8 12,7 0.81% | 12,1 12,5 -3.14% | 12,2 |
|
EBITDA Million USD | Released Forecast Spread | -70,2 -70,4 0.21% | -60,7 -57,8 -5.1% | -42,5 -42,5 0.09% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -72,8 -74,2 1.9% | -63,7 -63,1 -0.94% | -71,6 -60,4 -18.51% | -62,8 -60,9 -3.13% | -54,0 -52,2 -3.47% | -37,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -84,4 -85,2 0.87% | -78,2 -77,4 -0.97% | -77,7 -65,5 -18.56% | -62,6 -60,3 -3.76% | -60,8 -57,3 -6.14% | -49,0 |
|
Net income Million USD | Released Forecast Spread | -84,3 -85,1 0.98% | -78,2 -77,6 -0.84% | -77,7 -65,5 -18.63% | -62,5 -60,3 -3.64% | -61,6 -57,5 -7.09% | -49,0 |
|
EPS USD | Released Forecast Spread | -15,5 -15,6 0.75% | -14,0 -13,9 -1.03% | -12,6 -11,1 -13.26% | -7,60 -7,60 0% | -4,94 -4,63 -6.7% | -2,27 |
| Announcement Date | 27/02/20 | 23/02/21 | 08/03/22 | 29/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,34 3,25 2.86% | 2,96 2,95 0.27% | 3,86 3,10 24.55% | 2,96 3,75 -21.07% | 2,97 2,85 4.28% | 2,81 3,35 -16.06% | 2,92 3,60 -18.86% | 3,30 3,55 -7.07% | 3,03 3,45 -12.26% | 3,00 | 3,00 | 3,00 | 3,30 | 3,40 |
|
EBITDA Million USD | Released Forecast Spread | -11,3 -7,00 -61.14% | -14,7 -9,70 -51.6% | -10,1 -13,2 23.28% | -12,6 -12,2 -3.68% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -19,4 -12,3 -58.25% | -15,9 -15,6 -1.89% | -18,0 -16,0 -12.43% | -14,8 -13,1 -12.75% | -14,2 -12,2 -15.99% | -16,1 -10,2 -57.47% | -12,6 -13,6 7.46% | -13,5 -12,6 -6.87% | ||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -22,8 -14,9 -53.08% | -14,2 -19,2 26.12% | -17,8 -19,5 8.7% | -15,7 -13,4 -17.2% | -14,9 -12,6 -18.07% | -16,8 -11,4 -47.32% | -25,8 -14,9 -73.32% | 1,04 -13,2 107.89% | ||||||
|
Net income Million USD | Released Forecast Spread | -22,8 -14,9 -53.38% | -14,2 -19,2 26.12% | -17,8 -19,5 8.7% | -15,7 -13,4 -17.2% | -14,8 -12,6 -17.46% | -16,8 -11,4 -47.32% | -26,0 -14,9 -74.36% | 0,91 -13,2 106.89% | ||||||
|
EPS USD | Released Forecast Spread | -3,40 -2,50 -36% | -2,10 -3,00 30% | -2,30 -2,80 17.86% | -1,80 -1,95 7.69% | -1,40 -1,45 3.45% | -1,70 -1,45 -17.24% | -2,36 -1,40 -68.57% | 0,06 -1,07 105.61% | -0,81 -0,62 -30.65% | -0,72 | -0,56 | -0,51 | -0,50 | -0,49 |
| Announcement Date | 08/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
| 29/04/2024 06:00 | PHILIPS NV: Q1 2024 Earnings Release |
| 29/04/2024 11:00 | REVVITY, INC.: Q1 2024 Earnings Release |
| 30/04/2024 11:20 | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 30/04/2024 21:05 | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | INMODE LTD.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 02/05/2024 21:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Accelerate Diagnostics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AXDX Stock
- Calendar Accelerate Diagnostics, Inc.
